GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $991,000 | +45.7% | 22,872 | +85.5% | 0.00% | +33.3% |
| Q3 2020 | $680,000 | -13.5% | 12,330 | -0.9% | 0.00% | -25.0% |
| Q2 2020 | $786,000 | +13.7% | 12,443 | -8.0% | 0.00% | 0.0% |
| Q1 2020 | $691,000 | -60.3% | 13,526 | -38.2% | 0.00% | -55.6% |
| Q4 2019 | $1,741,000 | -30.3% | 21,904 | -57.5% | 0.01% | -35.7% |
| Q3 2019 | $2,499,000 | +7.2% | 51,495 | +16.1% | 0.01% | +7.7% |
| Q2 2019 | $2,332,000 | +15.0% | 44,341 | +15.8% | 0.01% | +8.3% |
| Q1 2019 | $2,027,000 | +653.5% | 38,298 | +483.8% | 0.01% | +500.0% |
| Q4 2018 | $269,000 | -22.7% | 6,560 | -28.3% | 0.00% | 0.0% |
| Q3 2018 | $348,000 | -11.0% | 9,150 | +5.8% | 0.00% | -33.3% |
| Q2 2018 | $391,000 | -32.1% | 8,650 | -27.5% | 0.00% | -25.0% |
| Q1 2018 | $576,000 | – | 11,935 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |